Evidence map›Paper›PMID 26705696›Full record

ArticleBMC infectious diseases2015

Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center.

Nicolas Degand, Romain Lotte, Célia Decondé Le Butor, Christine Segonds, Michelle Thouverez, Agnès Ferroni, Christine Vallier, Laurent Mély, Jacqueline Carrère

Abstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Clinical and microbiological characteristics of pediatricFrontiers in cellular and infection microbiology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Journal of clinical medicine · 2024
    Review
  6. Microbiome of lovebug (Microbiology spectrum · 2024
    Article
  7. Review
  8. Review
  9. Exploring the patient-microbiome interaction patterns for pan-cancer.Computational and structural biotechnology journal · 2022
    Article
  10. Sepsis Due toInfection and drug resistance · 2022
    Article
  11. Article
  12. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Infection and drug resistance · 2019
    Article
  17. Comparative Genomics ofFrontiers in microbiology · 2019
    Article
  18. Article
  19. Highly DiversifiedFrontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicolas DegandLaboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, Hôpital Archet II, Nice, France. degand.n@chu-nice.fr.
Romain LotteLaboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, Hôpital Archet II, Nice, France. lotte.r@chu-nice.fr.
Célia Decondé Le ButorLaboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, Hôpital Archet II, Nice, France. decondelebutor.c@chu-nice.fr.
Christine SegondsObservatoire Burkholderia cepacia, Laboratoire de Bactériologie, Hôpital Purpan, Toulouse, France. segonds.c@chu-toulouse.fr.
Michelle ThouverezLaboratoire de Bactériologie, Hôpital Jean Minjoz, Besançon, France. mthouverez@chu-besancon.fr.
Agnès FerroniLaboratoire de Bactériologie, Hôpital Necker-Enfants Malades, Paris, France. agnes.ferroni@nck.aphp.fr.
Christine VallierCRCM, Hôpital Renée Sabran, Giens, France. christine.vallier@chu-lyon.fr.
Laurent MélyCRCM, Hôpital Renée Sabran, Giens, France. laurent.mely@chu-lyon.fr.
Jacqueline CarrèreLaboratoire de Biologie, Hôpital Renée Sabran, Giens, France. jackycarrere@orange.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPandoraea spp. are recently discovered bacteria, mainly recovered from cystic fibrosis (CF) patients, but their epidemiology and clinical significance are not well known. We describe an epidemic spread of Pandoraea pulmonicola from 2009 in our CF center, involving 6 out of 243 CF patients.

methodsBacterial identification used amplified ribosomal DNA restriction analysis (ARDRA), MALDI-TOF mass spectrometry (MALDI-TOF MS) and 16S rDNA gene sequencing. The clonal link between strains was assessed with pulsed field gel electrophoresis (PFGE) using XbaI. Clinical data were gathered for all patients.

resultsThe index case was chronically colonized since 2000. The main hypothesis for this bacterial spread was a droplet cross-transmission, due to preventive measures not being strictly followed. Antibiotic susceptibility testing revealed resistance to beta-lactams, ciprofloxacin and colistin. However, there was susceptibility to trimethoprim-sulfamethoxazole. All patients were chronically colonized with Pseudomonas aeruginosa, and the acquisition of P. pulmonicola resulted in chronic colonization in all patients. Three patients died, and two patients remained clinically stable, whereas one patient had a decline in lung function.

conclusionsThis study, which is the first to describe an epidemic spread of P. pulmonicola, notes the potential transmissibility of this bacterial species and the need for infection control measures.

Indexed as

AdolescentAdultBurkholderiaceaeCystic FibrosisDNA, BacterialDrug Resistance, Multiple, BacterialElectrophoresis, Gel, Pulsed-FieldFemaleGram-Negative Bacterial InfectionsHumansInfection ControlMaleMiddle AgedPseudomonas aeruginosaRestriction MappingRNA, Ribosomal, 16SDNA, BacterialRNA, Ribosomal, 16STrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID26705696
PMCPMC4691299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.